Developing Small Molecule Therapeutics for the Initial and Adjunctive Treatment of Snakebite

Figure 2

Advantages and limitations of antivenom and SMTs. If proven effective, an SMT might address some limitations of antivenom and vice versa. (COGS = Cost of Goods).